Trade Names: | |
Synonyms: | |
Status: | Approved (2007) |
Entry Type: | Small molecule |
Molecule Category: | Salt Prodrug |
UNII: | SJT761GEGS |
Parent Compound: | LISDEXAMFETAMINE |
InChI Key | CETWSOHVEGTIBR-FORAGAHYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C17H33N3O7S2 |
Molecular Weight | 455.6 |
AlogP | 1.19 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 8.0 |
Polar Surface Area | 81.14 |
Molecular species | BASE |
Aromatic Rings | 1.0 |
Heavy Atoms | 19.0 |
Action | Mechanism of Action | Reference |
---|---|---|
RELEASING AGENT | Dopamine transporter releasing agent | DailyMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Attention Deficit Disorder with Hyperactivity | 4 | D001289 | ClinicalTrials |
Depressive Disorder, Major | 3 | D003865 | ClinicalTrials |
Schizophrenia | 3 | D012559 | ClinicalTrials |
Feeding and Eating Disorders | 3 | D001068 | ClinicalTrials |
Obesity | 2 | D009765 | ClinicalTrials |
Sleep Initiation and Maintenance Disorders | 2 | D007319 | ClinicalTrials |
Bulimia Nervosa | 2 | D052018 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL1201178 |
EPA CompTox | DTXSID60209653 |
FDA SRS | SJT761GEGS |
PharmGKB | PA164748975 |
PubChem | 11597697 |
SureChEMBL | SCHEMBL678421 |